Receptor-Smad2 and co-Smad4, like TβRI, were equally expressed in the different HCC cell lines, whereas Smad3 exhibited strikingly high mRNA and protein expression in HLE and HLF (Figure 2C, Figure S3). This evidence concerns the gene SMAD3 and hepatocellular carcinoma.